SY-1425, a potent and selective RARα agonist, in combination with azacitidine demonstrates a high complete response rate and a rapid onset of response in RARA-positive newly diagnosed unfit acute myeloid leukemia Meeting Abstract
| Authors: | De Botton, S.; Cluzeau, T.; Vigil, C. E.; Cook, R. J.; Rousselot, P.; Rizzieri, D. A.; Liesveld, J. L.; Fenaux, P.; Braun, T.; Banos, A.; Savona, M. R.; Park, D.; Kelly, M. J.; Volkert, A.; Zhou, L.; Kang-Fortner, Q.; Roth, D. A.; Stein, E. M. |
| Abstract Title: | SY-1425, a potent and selective RARα agonist, in combination with azacitidine demonstrates a high complete response rate and a rapid onset of response in RARA-positive newly diagnosed unfit acute myeloid leukemia |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205603253 |
| DOI: | 10.1182/blood-2020-134600 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4 -- Source: Wos |
